These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19 and 3A4 activities in human liver microsomes. Laine K; Yasar U; Widén J; Tybring G Pharmacol Toxicol; 2003 Aug; 93(2):77-81. PubMed ID: 12899669 [TBL] [Abstract][Full Text] [Related]
23. Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate. Kobayashi K; Mimura N; Fujii H; Minami H; Sasaki Y; Shimada N; Chiba K Clin Cancer Res; 2000 Aug; 6(8):3297-303. PubMed ID: 10955816 [TBL] [Abstract][Full Text] [Related]
24. Human hepatocytes in primary culture predict lack of cytochrome P-450 3A4 induction by eletriptan in vivo. Pichard-Garcia L; Hyland R; Baulieu J; Fabre JM; Milton A; Maurel P Drug Metab Dispos; 2000 Jan; 28(1):51-7. PubMed ID: 10611140 [TBL] [Abstract][Full Text] [Related]
25. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism. Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822 [TBL] [Abstract][Full Text] [Related]
26. Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study. Pai AB; Norenberg J; Boyd A; Raj D; Chan LN Clin Ther; 2007 Dec; 29(12):2699-705. PubMed ID: 18201586 [TBL] [Abstract][Full Text] [Related]
27. Effect of CYP3A inhibition on vesnarinone metabolism in humans. Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823 [TBL] [Abstract][Full Text] [Related]
28. In vivo effect of I'm-Yunity on hepatic cytochrome P450 3A4. Nicandro JP; Tsourounis C; Frassetto L; Guglielmo BJ J Herb Pharmacother; 2007; 7(1):39-56. PubMed ID: 17594986 [TBL] [Abstract][Full Text] [Related]
29. The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity. Kurnik D; Wood AJ; Wilkinson GR Clin Pharmacol Ther; 2006 Sep; 80(3):228-34. PubMed ID: 16952489 [TBL] [Abstract][Full Text] [Related]
30. Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Villikka K; Kivistö KT; Mäenpää H; Joensuu H; Neuvonen PJ Clin Pharmacol Ther; 1999 Dec; 66(6):589-93. PubMed ID: 10613614 [TBL] [Abstract][Full Text] [Related]
31. Omeprazole does not affect measured CYP3A4 activity using the erythromycin breath test. Tateishi T; Graham SG; Krivoruk Y; Wood AJ Br J Clin Pharmacol; 1995 Oct; 40(4):411-2. PubMed ID: 8554946 [No Abstract] [Full Text] [Related]
32. Effect of the adrenal 11-beta-hydroxylase inhibitor metyrapone on human hepatic cytochrome P-450 expression: induction of cytochrome P-450 3A4. Harvey JL; Paine AJ; Maurel P; Wright MC Drug Metab Dispos; 2000 Jan; 28(1):96-101. PubMed ID: 10611146 [TBL] [Abstract][Full Text] [Related]
33. Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis. Wang RW; Newton DJ; Scheri TD; Lu AY Drug Metab Dispos; 1997 Apr; 25(4):502-7. PubMed ID: 9107550 [TBL] [Abstract][Full Text] [Related]
34. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Buters JT; Korzekwa KR; Kunze KL; Omata Y; Hardwick JP; Gonzalez FJ Drug Metab Dispos; 1994; 22(5):688-92. PubMed ID: 7835218 [TBL] [Abstract][Full Text] [Related]
35. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes. Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607 [TBL] [Abstract][Full Text] [Related]
36. Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation. Jones DR; Gorski JC; Haehner BD; O'Mara EM; Hall SD Clin Pharmacol Ther; 1996 Oct; 60(4):374-84. PubMed ID: 8873685 [TBL] [Abstract][Full Text] [Related]